Radiologist takes over at NIBIB
The imaging community had more to cheer May 7 when the NIH announced the appointment of Dr. Roderic I. Pettigrew as the first permanent director of the National Institute of Biomedical Imaging and Bioengineering. Pettigrew's background in radiology and
The imaging community had more to cheer May 7 when the NIH announced the appointment of Dr. Roderic I. Pettigrew as the first permanent director of the National Institute of Biomedical Imaging and Bioengineering. Pettigrew's background in radiology and engineering makes him an ideal candidate for this NIH division, which addresses a wide range of biomedical technologies. Currently the director of Emory University's Center for MR Research, Pettigrew holds a doctorate from the Massachusetts Institute of Technology's department of nuclear engineering in applied radiation physics. He is also the immediate past chair of the diagnostic imaging study section at the Center for Scientific Review at NIH--the section that reviews grant applications to develop and evaluate new imaging technology, including instrumentation and software for producing, evaluating, storing, and transmitting images.
Emerging AI Mammography Model May Enhance Clarity for Initial BI-RADS 3 and 4 Classifications
May 21st 2025In a study involving over 12,000 Asian women, researchers found that an artificial intelligence (AI) model converted over 83 percent of false positives in patients with initial BI-RADS 3 and 4 assessments into benign BI-RADS categories.
Study: Abbreviated Breast MRI Offers Equivalent Accuracy to mpMRI for Women with Dense Breasts
May 20th 2025Emerging research suggests that abbreviated breast MRI offers comparable sensitivity and specificity as multiparametric MRI in women with extremely dense breasts with a nearly 50 percent reduction in reading time for radiologists.
Can AI Predict Future Lung Cancer Risk from a Single CT Scan?
May 19th 2025In never-smokers, deep learning assessment of single baseline low-dose computed tomography (CT) scans demonstrated a 79 percent AUC for predicting lung cancer up to six years later, according to new research presented today at the American Thoracic Society (ATS) 2025 International Conference.
